LS CancerDiag

LS CancerDiag Overview

  • Founded
  • 2013
  • Status
  • Private
  • Latest Deal Type
  • Accelerator/​Inc
  • Investors
  • 3

LS CancerDiag General Information


Developer of a predictive cancer diagnostic method intended to reduce cancer mortality rates. The company's technology, DiagMMR assay is an easy functional test that can be used for diagnosis of MMR deficiency i.e. Lynch syndrome and simplifies diagnostics of Lynch syndrome by delivering predictive and accurate results with a fast, unique and cost-efficient method globally, enabling patients to save their lives through early detection of cancer.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Diagnostic Equipment
Other Industries
Primary Office
  • C/O Terkko Health Hub
  • Haartmaninkatu 4, Building 14
  • 00290 Helsinki
  • Finland
+358 040 0000000

LS CancerDiag Timeline

Financing Round
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

LS CancerDiag Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Accelerator/Incubator 01-Jan-2019 Completed Startup
2. Accelerator/Incubator 01-Jan-2018 Completed Startup
1. Accelerator/Incubator 01-Jan-2016 Completed Startup

LS CancerDiag Executive Team (3)

Name Title Board Seat Contact Info
Niklas Lahti Chief Financial Officer
Minttu Kansikas Ph.D Chief Scientific Officer
Philippe Arnez Chief Business Officer

LS CancerDiag Board Members (1)

Name Representing Role Since
Minna Nyström LS CancerDiag Founder & Chairman 000 0000

LS CancerDiag Investors (3)

To view LS CancerDiag‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Invest Horizon Government Minority 000 0000 000000 0
Life Science Accelerator Accelerator/Incubator Minority 000 0000 000000 0
StartUp Health Venture Capital Minority 000 0000 000000 0

Ready to get started?

Request a free trial